Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages 1060-1067

  Lipworth, Adam D ^a,b   Park, Jong Min ^a   Trefrey, Brie L ^a   Rubin, Krista M ^a   Geller, Alan C ^c   Sober, Arthur J ^a,b   Tsao, Hensin ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Harvard Combined Orthopaedic Residency Program   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

detection; melanoma; pigmented lesion; pigmented lesion clinic; routine visit; urgent access; urgent access track

Indexed keywords

ACTINIC KERATOSIS; ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DERMATOFIBROMA; DISTANT METASTASIS; EARLY DIAGNOSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE; URGENT ACCESS TRACK; VASCULAR LESION; VERRUCA VULGARIS;

BOSTON; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, GENERAL; HOSPITALS, URBAN; HUMANS; MALE; MELANOMA; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TRIAGE;

EID: 79956094339     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.08.021     Document Type: Article

References (28)

1. Pollitt RA, Clarke CA, Shema SJ, Swetter SM. California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Am J Prev Med 2008;35:7-13.
2. Pacifico MD, Pearl RA, Grover R. The UK government two-week rule and its impact on melanoma prognosis: an evidence-based study. Ann R Coll Surg Engl 2007;89:609-15. (Pubitemid 47408293)
3. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007;82:364-80. (Pubitemid 46348938)
4. Resneck J Jr, Kimball AB. The dermatology workforce shortage. J Am Acad Dermatol 2004;50:50-4. (Pubitemid 38095650)
5. Tsang MW, Resneck JS Jr. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol 2006;55:54-8. (Pubitemid 43867047)
6. Resneck JS Jr, Kimball AB. Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians. J Am Acad Dermatol 2008;58:211-6.
7. Baade PD, Youl PH, English DR, Mark Elwood J, Aitken JF. Clinical pathways to diagnose melanoma: a population-based study. Melanoma Res 2007;17:243-9. (Pubitemid 47067083)
8. Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007;143:488-94. (Pubitemid 46631647)
9. Massone C, Wurm EM, Hofmann-Wellenhof R, Soyer HP. Teledermatology: an update. Semin Cutan Med Surg 2008;27:101-5. (Pubitemid 351657721)
10. Massone C, Hofmann-Wellenhof R, Ahlgrimm-Siess V, Gabler G, Ebner C, Soyer HP. Melanoma screening with cellular phones. PLoS One 2007;2:e483.
11. Provost N, Kopf AW, Rabinovitz HS, Stolz W, DeDavid M, Wasti Q, et al. Comparison of conventional photographs and telephonically transmitted compressed digitized images of melanomas and dysplastic nevi. Dermatology 1998;196:299-304. (Pubitemid 28224809)
12. Bowns IR, Collins K, Walters SJ, McDonagh AJ. Telemedicine in dermatology: a randomized controlled trial. Health Technol Assess 2006;10:iii-iv, ix-xi, 1-39.
13. Moreno-Ramirez D, Ferrandiz L, Bernal AP, Duran RC, Martin JJ, Camacho F. Teledermatology as a filtering system in pigmented lesion clinics. J Telemed Telecare 2005;11:298-303. (Pubitemid 41366663)
14. Warshaw EM, Lederle FA, Grill JP, Gravely AA, Bangerter AK, Fortier LA, et al. Accuracy of teledermatology for pigmented neoplasms. J Am Acad Dermatol 2009;61:753-65.
15. Graves J, Fleischman MH, Goldstein GD. Derm access: a new triage system to rapidly identify suspicious skin lesions. Dermatol Surg 2006;32:1486-90. (Pubitemid 44934898)
16. Stanway A, Oakley A, Rademaker M, Duffill M. Audit of acute referrals to the department of dermatology at Waikato Hospital: comparison with national access criteria for first specialist appointment. N Z Med J 2004;117:U849.
17. Anderson BE, Marks JG Jr, Downs E, Buckel T, Adams DR, Enterline J, et al. The Hershey access clinic: a model for improving patient access. J Am Acad Dermatol 2007;57:601-3. (Pubitemid 47384919)
18. Carli P, De Giorgi V, Giannotti B, Seidenari S, Pellacani G, Peris K, et al. Skin cancer day in Italy: method of referral to open access clinics and tumor prevalence in the examined population. Eur J Dermatol 2003;13:76-9. (Pubitemid 36228515)
19. Einwachter-Thompson J, Mackie RM. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis. Br J Dermatol 2008;159:337-41. (Pubitemid 352009840)
20. Rubin KM, Lawrence DP. Your patient with melanoma: staging, prognosis, and treatment. Oncology (Williston Park) 2009;23(Suppl):13-21.
21. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome; a 20-year experience. Int J Radiat Oncol Biol Phys 1999;44:607-18. (Pubitemid 29258436)
22. Wornom IL III, Smith JW, Soong SJ, McElvein R, Urist MM, Balch CM. Surgery as palliative treatment for distant metastases of melanoma. Ann Surg 1986;204:181-5.
23. Tomov T, Siegel R, Bembenek A. Long-term survival in stage IV melanoma after repetitive surgical therapy. Onkologie 2008;31:259-61. (Pubitemid 351744826)
24. Hamid NA, Chandra A, Meyer CH. Multiple brain metastases from malignant melanoma with long-term survival. Br J Neurosurg 2004;18:552-5.
25. Markowitz JS, Cosimi LA, Carey RW, Kang S, Padyk C, Sober AJ, et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991;126:703-8.
26. Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007;14:1924-33. (Pubitemid 46870937)
27. Francken AB, Shaw HM, Thompson JF. Detection of second primary cutaneousmelanomas. Eur J SurgOncol 2008;34:587-92.
28. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localized primary cutaneous melanoma. Lancet Oncol 2005;6:608-21. (Pubitemid 41051939)